This opportunity is no longer accepting applications.
grant PAR-23-158

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)

This funding opportunity supports exploratory and developmental clinical research aimed at understanding the neurobiological mechanisms behind substance use disorders (SUD) and related brain functions. It uses a phased award system (R61/R33) and is intended for projects needing larger budgets than those allowed under the R21 mechanism.

This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Dates

Opportunity Released: April 10, 2023
Open for Submission: April 10, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.